Nanomedicine, Public Health & Uncertainty
December 15, 2015
Dean and Professor of Toxicology, University of Michigan School of Public Health
Martin Philbert is professor of toxicology and dean of the University of Michigan School of Public Health. He earned his bachelor’s degree in 1984 from the College of Arts and Technology at Cambridge and his doctorate in 1987 from the London University Royal Postgraduate Medical School. He was awarded a postdoctoral fellowship in the Neurotoxicology Laboratories at Rutgers University from 1988 to 1990. Philbert served as a research assistant professor at Rutgers’ Neurotoxicology Laboratories until 1995, when he joined the faculty at the University of Michigan School of Public Health as an assistant professor of toxicology. He was promoted to associate professor in 2000 and to professor in 2004. He served as associate chair for research and development in the environmental health sciences department from 2000 to 2003. In 2004, Philbert was appointed senior associate dean for research of the University of Michigan School of Public Health, a position he held through 2010 when he was appointed dean. He also served as interim director of the Center for Risk Science and Communication from 2004 to 2010.
Philbert has maintained a continuously federally funded portfolio of basic research activities throughout his career. His research focuses on the development of flexible polymer nanoplatforms for optical sensing of ions and small molecules and the early detection and treatment of brain tumors. Other research interests include the mitochondrial mechanisms of chemically induced neuropathic states. Most recently his work has been funded by the National Institutes of Health, the Department of Air Force, and the National Cancer Institute. He is the author of more than 150 peer-reviewed scholarly manuscripts, abstracts, and book chapters.
Philbert is chair of the newly formed US–EPA Chemical Assessment Advisory Committee, which provides peer review of risk assessments produced under the auspices of the EPA’s Integrated Risk Information System, and is a standing member of the Agency’s Science Advisory Board. He also served a four-year term on the National Advisory Environmental Health Sciences Council of the National Institute of Environmental Health Sciences and provides consultation to the federal agencies on a variety of issues surrounding emerging nanotechnologies, nanomedicine, health, and safety. Philbert is an elected member of the Institute of Medicine of the National Academies of Science (USA), a fellow of the Royal Society of Chemistry (UK), a fellow of the Academy of Toxicological Sciences (USA), and a member of the Division of Earth and Life Sciences of the National Academy of Science (USA).